Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

CLNN Insider Trading

Clene Inc. | Pharmaceutical Preparations

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Clene Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Pharmaceutical Preparations sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2026-04-06 21:32 2026-04-02 Ugwumba Chidozie 10% owner SELL $4.81 24,925 $119,889 401,891 -5.8%
2026-04-01 21:10 2026-04-01 Ugwumba Chidozie 10% owner SELL $4.97 4,278 $21,262 426,816 -1.0%
2026-03-31 20:35 2026-03-27 Ugwumba Chidozie 10% owner SELL $4.89 100,997 $494,017 431,094 -19.0%
2026-03-26 21:39 2026-03-24 Ugwumba Chidozie 10% owner SELL $5.56 17,909 $99,506 532,091 -3.3%
2026-02-05 18:18 2026-02-03 Ugwumba Chidozie 10% owner SELL $4.10 5,559 $22,792 550,000 -1.0%
2026-02-03 01:10 2026-01-29 Ugwumba Chidozie 10% owner SELL $4.23 24,770 $104,861 555,559 -4.3%
2026-01-29 01:01 2026-01-26 Ugwumba Chidozie 10% owner SELL $4.98 19,274 $96,044 580,329 -3.2%
2026-01-24 01:33 2026-01-22 Ugwumba Chidozie 10% owner SELL $5.30 18,221 $96,659 599,603 -2.9%
2026-01-22 02:13 2026-01-16 Ugwumba Chidozie 10% owner SELL $4.97 32,474 $161,519 617,824 -5.0%
2026-01-16 19:16 2026-01-13 Ugwumba Chidozie 10% owner SELL $5.01 58,289 $292,185 650,298 -8.2%
2026-01-13 22:48 2026-01-13 MATLIN DAVID J Director BUY $6.50 33,333 $216,665 477,824 +7.5%
2026-01-13 00:38 2026-01-08 Ugwumba Chidozie 10% owner SELL $5.70 44,975 $256,236 708,587 -6.0%
2026-01-08 01:28 2026-01-05 Ugwumba Chidozie 10% owner SELL $6.04 12,918 $78,012 753,562 -1.7%
2026-01-03 01:25 2025-12-31 Ugwumba Chidozie 10% owner SELL $5.79 17,110 $99,087 766,480 -2.2%
2025-12-31 20:10 2025-12-29 Ugwumba Chidozie 10% owner SELL $5.98 12,234 $73,124 783,590 -1.5%
2025-12-31 05:03 2025-12-23 Ugwumba Chidozie 10% owner SELL $6.28 11,671 $73,345 795,824 -1.4%
2025-12-24 00:37 2025-12-19 Ugwumba Chidozie 10% owner SELL $6.49 9,949 $64,564 383,201 -2.5%
2025-12-19 01:08 2025-12-03 Ugwumba Chidozie 10% owner SELL $6.69 257,795 $1,725,731 393,150 -39.6%
2025-08-22 03:44 2025-08-21 General Resonance LLC 10% owner SELL $5.34 3,401 $18,161 704,591 -0.5%
2025-06-04 22:23 2025-06-04 General Resonance LLC 10% owner SELL $4.04 600 $2,424 707,992 -0.1%
2025-06-02 21:39 2025-06-02 General Resonance LLC 10% owner SELL $4.12 600 $2,473 708,592 -0.1%
2025-05-30 21:40 2025-05-30 General Resonance LLC 10% owner SELL $2.80 410 $1,148 709,192 -0.1%
2025-05-29 22:58 2025-05-29 General Resonance LLC 10% owner SELL $2.73 410 $1,119 709,602 -0.1%
2025-05-28 21:05 2025-05-28 General Resonance LLC 10% owner SELL $2.60 420 $1,090 710,012 -0.1%
2025-05-27 22:29 2025-05-27 General Resonance LLC 10% owner SELL $2.45 420 $1,029 710,432 -0.1%
2025-03-20 01:47 2025-03-18 General Resonance LLC 10% owner SELL $4.42 2,733 $12,092 710,852 -0.4%
2024-10-02 19:58 2024-09-30 MATLIN DAVID J Director BUY $4.75 92,307 $438,458 444,491 +26.2%
2024-10-01 23:17 2024-09-30 Mortenson Mark Officer - Chief Science Officer BUY $4.75 20,512 $97,432 28,949 +243.1%
2024-10-01 23:17 2024-09-30 Etherington Robert Dee Director, Officer - Chief Executive Officer BUY $4.75 10,000 $47,500 40,149 +33.2%
2024-05-08 19:16 2024-04-30 General Resonance LLC 10% owner SELL $0.41 26,000 $10,564 15,313,712 -0.2%
2024-05-02 00:13 2024-04-24 General Resonance LLC 10% owner SELL $0.33 10,000 $3,278 15,349,712 -0.1%
2024-04-16 16:38 2024-04-09 General Resonance LLC 10% owner SELL $0.39 22,500 $8,674 15,428,212 -0.1%
2023-11-13 15:48 2023-11-10 MATLIN DAVID J Director BUY $0.41 250,002 $102,501 7,043,686 +3.7%
2023-09-08 23:33 2023-06-16 Ugwumba Chidozie 10% owner, Other BUY $0.80 7,500,000 $6,000,000 13,018,908 +135.9%
2023-06-27 21:13 2023-06-26 Stevens John Henry Director BUY $0.80 316,455 $253,164 800,204 +65.4%
2023-06-27 15:07 2023-06-26 Etherington Robert Dee Director, Officer - Chief Executive Officer BUY $0.81 25,000 $20,250 25,000 +100.0%
2023-06-20 18:02 2023-06-16 Mosca Alison Director BUY $0.80 2,394,375 $1,915,500 3,238,375 +283.7%
2023-06-20 16:50 2023-06-16 Gay Jonathon Director BUY $0.80 105,625 $84,500 105,625 +100.0%
2023-06-20 14:57 2023-06-16 MATLIN DAVID J Director BUY $0.80 1,500,000 $1,200,000 6,793,684 +28.3%
2022-11-03 15:04 2022-11-02 Gay Jonathon Director BUY $1.01 990,099 $1,000,000 2,154,848 +85.0%
2022-11-03 14:58 2022-11-02 Ugwumba Chidozie Director BUY $1.01 990,099 $1,000,000 5,518,908 +21.9%
2022-11-03 14:57 2022-11-02 Mosca Alison Director BUY $1.01 792,079 $800,000 844,000 +1,525.5%
2022-11-03 14:55 2022-11-02 Stevens John Henry Director BUY $1.01 148,515 $150,000 483,749 +44.3%
2022-11-03 15:07 2022-11-02 MATLIN DAVID J Director BUY $1.01 2,871,287 $2,900,000 5,293,684 +118.5%
2022-08-18 19:54 2022-08-17 Stevens John Henry Director BUY $3.85 47,662 $183,499 335,234 +16.6%
2022-07-19 23:08 2022-07-18 Etherington Robert Dee Director, Officer - Chief Executive Officer SELL $4.72 23,483 $110,840 56,593 -29.3%
2022-06-21 14:00 2022-06-16 MATLIN DAVID J Director BUY $2.51 149,610 $374,773 2,422,397 +6.6%
2022-06-17 22:33 2022-06-16 Mortenson Mark Officer - Chief Science Officer SELL $2.47 20,247 $50,010 168,759 -10.7%
2022-06-16 14:14 2022-06-15 Mosca Alison Director BUY $2.62 5,000 $13,100 39,476 +14.5%
2022-06-16 14:13 2022-06-14 MATLIN DAVID J Director BUY $2.66 96,011 $255,389 2,272,787 +4.4%
SHOW ENTRIES

How to Interpret $CLNN Trades

Not every insider transaction in Clene Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $CLNN shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for CLNN

Insider activity data for Clene Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $CLNN, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.